Sander D. Borgsteede

1.5k total citations
57 papers, 968 citations indexed

About

Sander D. Borgsteede is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Sander D. Borgsteede has authored 57 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Geriatrics and Gerontology, 16 papers in Pediatrics, Perinatology and Child Health and 14 papers in Pharmacology. Recurrent topics in Sander D. Borgsteede's work include Pharmaceutical Practices and Patient Outcomes (26 papers), Drug-Induced Hepatotoxicity and Protection (10 papers) and Palliative Care and End-of-Life Issues (10 papers). Sander D. Borgsteede is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (26 papers), Drug-Induced Hepatotoxicity and Protection (10 papers) and Palliative Care and End-of-Life Issues (10 papers). Sander D. Borgsteede collaborates with scholars based in Netherlands, United States and Belgium. Sander D. Borgsteede's co-authors include Patricia M. L. A. van den Bemt, Fatma Karapinar‐Çarkit, Luc Deliëns, Anneke L. Francke, Dick L. Willems, Toine C. G. Egberts, Katja Taxis, Gerrit van der Wal, Jacqueline G. Hugtenburg and Jacques ThM van Eijk and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Sander D. Borgsteede

51 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sander D. Borgsteede Netherlands 21 365 273 238 167 148 57 968
B. Charpiat France 19 731 2.0× 52 0.2× 272 1.1× 106 0.6× 87 0.6× 98 1.2k
Ejaz Cheema United Kingdom 16 358 1.0× 106 0.4× 105 0.4× 180 1.1× 164 1.1× 56 932
R. Janknegt Netherlands 20 232 0.6× 81 0.3× 204 0.9× 161 1.0× 88 0.6× 80 1.3k
Ingebjørg Buajordet Norway 9 265 0.7× 118 0.4× 191 0.8× 68 0.4× 36 0.2× 17 838
Sherilyn K. D. Houle Canada 18 472 1.3× 216 0.8× 83 0.3× 405 2.4× 112 0.8× 117 1.3k
Jerry Avorn United States 15 302 0.8× 92 0.3× 79 0.3× 184 1.1× 127 0.9× 23 1.4k
Robert K. Hallisey United States 7 804 2.2× 82 0.3× 223 0.9× 120 0.7× 117 0.8× 10 1.5k
Johanna Jyrkkä Finland 15 827 2.3× 150 0.5× 177 0.7× 176 1.1× 215 1.5× 36 1.5k
Lisha Lo Canada 8 335 0.9× 157 0.6× 126 0.5× 328 2.0× 118 0.8× 18 1.1k
Sherrie L. Aspinall United States 22 618 1.7× 97 0.4× 138 0.6× 176 1.1× 162 1.1× 63 1.4k

Countries citing papers authored by Sander D. Borgsteede

Since Specialization
Citations

This map shows the geographic impact of Sander D. Borgsteede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander D. Borgsteede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander D. Borgsteede more than expected).

Fields of papers citing papers by Sander D. Borgsteede

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sander D. Borgsteede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander D. Borgsteede. The network helps show where Sander D. Borgsteede may publish in the future.

Co-authorship network of co-authors of Sander D. Borgsteede

This figure shows the co-authorship network connecting the top 25 collaborators of Sander D. Borgsteede. A scholar is included among the top collaborators of Sander D. Borgsteede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sander D. Borgsteede. Sander D. Borgsteede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borgsteede, Sander D., et al.. (2022). Evaluation of medication-related problems in liver transplant recipients with and without an outpatient medication consultation by a clinical pharmacist: a cohort study. International Journal of Clinical Pharmacy. 44(5). 1114–1122. 2 indexed citations
2.
Drenth, Joost P.H., et al.. (2022). Why zolpidem increases the risk of falls and fractures in patients with cirrhosis. JHEP Reports. 4(12). 100528–100528. 2 indexed citations
3.
Dijk, Liset van, et al.. (2021). The impact of textual elements on the comprehensibility of drug label instructions (DLIs): A systematic review. PLoS ONE. 16(5). e0250238–e0250238. 6 indexed citations
4.
Borgsteede, Sander D., et al.. (2021). Medication-Related Problems in Liver Transplant Recipients in the Outpatient Setting: A Dutch Cohort Study. Frontiers in Pharmacology. 12. 637090–637090. 3 indexed citations
5.
Drenth, Joost P.H., et al.. (2020). Veilig voorschrijven bij levercirrose: 5 misvattingen. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 164.
6.
Sijs, Heleen van der, et al.. (2020). The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion. Frontiers in Pharmacology. 11. 707–707. 11 indexed citations
7.
8.
Drenth, Joost P.H., et al.. (2019). Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is Available. Hepatology Communications. 3(9). 1281–1282.
9.
Boer, Anthonius de, et al.. (2019). Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patients. British Journal of Clinical Pharmacology. 86(4). 763–770. 2 indexed citations
10.
Burger, David M., et al.. (2019). Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations. Expert Opinion on Drug Metabolism & Toxicology. 16(1). 45–57. 24 indexed citations
11.
Mol, Peter G. M., et al.. (2019). Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment. Frontiers in Pharmacology. 10. 1031–1031. 17 indexed citations
12.
Bouma, Margriet, David M. Burger, Joost P.H. Drenth, et al.. (2018). Safe use of proton pump inhibitors in patients with cirrhosis. British Journal of Clinical Pharmacology. 84(8). 1806–1820. 35 indexed citations
13.
Borgsteede, Sander D., et al.. (2018). Etiketteksten op de schop voor beter begrip van patiënt. Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam). 135(10). 30–31.
14.
Taxis, Katja, et al.. (2018). Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study. Drug Safety. 42(4). 539–546. 21 indexed citations
15.
Bouma, Margriet, David M. Burger, Joost P.H. Drenth, et al.. (2018). Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis. Drug Safety. 41(6). 603–613. 33 indexed citations
16.
Taxis, Katja, et al.. (2018). Preventing dispensing errors by alerting for drug confusions in the pharmacy information system—A survey of users. PLoS ONE. 13(5). e0197469–e0197469. 16 indexed citations
17.
Bouma, Margriet, David M. Burger, Joost P.H. Drenth, et al.. (2016). Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion. BMJ Open. 6(10). e012991–e012991. 23 indexed citations
18.
Karapinar‐Çarkit, Fatma, et al.. (2014). Completeness of patient records in community pharmacies post-discharge after in-patient medication reconciliation: a before-after study. International Journal of Clinical Pharmacy. 36(4). 807–814. 10 indexed citations
19.
Borgsteede, Sander D., et al.. (2010). Information needs about medication according to patients discharged from a general hospital. Patient Education and Counseling. 83(1). 22–28. 67 indexed citations
20.
Borgsteede, Sander D., et al.. (2008). Voorlichting over geneesmiddelen aan patiënten met diabetes mellitus type 2 moet worden uitgebreid.. Pure Amsterdam UMC. 143(12). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Charpiat Breakdown of academic impact, for papers by Ejaz Cheema Breakdown of academic impact, for papers by R. Janknegt Breakdown of academic impact, for papers by Ingebjørg Buajordet Breakdown of academic impact, for papers by Sherilyn K. D. Houle Breakdown of academic impact, for papers by Jerry Avorn Breakdown of academic impact, for papers by Robert K. Hallisey Breakdown of academic impact, for papers by Johanna Jyrkkä Breakdown of academic impact, for papers by Lisha Lo Breakdown of academic impact, for papers by Sherrie L. Aspinall
Rankless by CCL
2026